STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
EXEL EXELIXIS INCORPORATED StockScouter® Report
6
StockScouter® Score
EXELIXIS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
- The ratio of EXEL’s forward price-to-earnings multiple to its estimated growth rate is below the average of comparably-sized companies in the StockScouter universe. Positive
Concerns
- An executive, director or major shareholder sold a large number of shares recently. Negative
- Shares are being sold by financial institutions. Slighlty negative for a large company like EXEL
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
D
C
C